These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31339295)

  • 21. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
    Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo ultrasound-activated delivery of recombinant tissue plasminogen activator from the cavity of sub-micrometric capsules.
    Correa-Paz C; Navarro Poupard MF; Polo E; Rodríguez-Pérez M; Taboada P; Iglesias-Rey R; Hervella P; Sobrino T; Vivien D; Castillo J; Del Pino P; Campos F; Pelaz B
    J Control Release; 2019 Aug; 308():162-171. PubMed ID: 31310784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection.
    Yu W; Yin N; Yang Y; Xuan C; Liu X; Liu W; Zhang Z; Zhang K; Liu J; Shi J
    Acta Biomater; 2022 Mar; 140():625-640. PubMed ID: 34902617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.
    Leys D; Hommet Y; Jacquet C; Moulin S; Sibon I; Mas JL; Moulin T; Giroud M; Sagnier S; Cordonnier C; Medeiros de Bustos E; Turc G; Ronzière T; Bejot Y; Detante O; Ouk T; Mendyk AM; Favrole P; Zuber M; Triquenot-Bagan A; Ozkul-Wermester O; Montoro FM; Lamy C; Faivre A; Lebouvier L; Potey C; Poli M; Hénon H; Renou P; Dequatre-Ponchelle N; Bodenant M; Debruxelles S; Rossi C; Bordet R; Vivien D;
    Neurology; 2016 Dec; 87(23):2416-2426. PubMed ID: 27815401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?
    Haelewyn B; Risso JJ; Abraini JH
    J Cereb Blood Flow Metab; 2010 May; 30(5):900-3. PubMed ID: 20216551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator.
    Cipolla MJ; Lessov N; Clark WM; Haley EC
    Stroke; 2000 Apr; 31(4):940-5. PubMed ID: 10754003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
    Gosser RA; Arndt RF; Schaafsma K; Dang CH
    J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
    Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single- and two- chain tissue type plasminogen activator treatments differentially influence cerebral recovery after stroke.
    Anfray A; Brodin C; Drieu A; Potzeha F; Dalarun B; Agin V; Vivien D; Orset C
    Exp Neurol; 2021 Apr; 338():113606. PubMed ID: 33453214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
    Yagi K; Kitazato KT; Uno M; Tada Y; Kinouchi T; Shimada K; Nagahiro S
    Stroke; 2009 Feb; 40(2):626-31. PubMed ID: 19095969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitro.
    Mutch NJ; Moore NR; Mattsson C; Jonasson H; Green AR; Booth NA
    Br J Pharmacol; 2008 Jan; 153(1):124-31. PubMed ID: 17982476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New progress in the approaches for blood-brain barrier protection in acute ischemic stroke.
    Li Y; Zhong W; Jiang Z; Tang X
    Brain Res Bull; 2019 Jan; 144():46-57. PubMed ID: 30448453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Sonothrombolysis Using Microbubbles Produced by a Catheter-Based Microfluidic Device in a Rat Model of Ischemic Stroke.
    Dixon AJ; Li J; Rickel JR; Klibanov AL; Zuo Z; Hossack JA
    Ann Biomed Eng; 2019 Apr; 47(4):1012-1022. PubMed ID: 30689066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.
    Tatlisumak T; Strbian D; Abo Ramadan U; Li F
    Curr Vasc Pharmacol; 2004 Oct; 2(4):343-55. PubMed ID: 15320814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
    Jin R; Xiao AY; Chen R; Granger DN; Li G
    Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonosensitive capsules for brain thrombolysis increase ischemic damage in a stroke model.
    Correa-Paz C; Navarro Poupard MF; Polo E; Rodríguez-Pérez M; Migliavacca M; Iglesias-Rey R; Ouro A; Maqueda E; Hervella P; Sobrino T; Castillo J; Del Pino P; Pelaz B; Campos F
    J Nanobiotechnology; 2022 Jan; 20(1):46. PubMed ID: 35062954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: role of hemodynamic alterations.
    Kilic E; Bähr M; Hermann DM
    Stroke; 2001 Nov; 32(11):2641-7. PubMed ID: 11692029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.